Dan Dearen

Dan Dearen has over 30 years of experience in senior management roles with emerging growth companies in medical devices, life sciences, and technology. Dan is currently co-founder and chief operating and financial officer of Axonics Modulation Technologies, developer of the first rechargeable Sacral Neuromodulation (r-SNM™) system for the treatment of overactive bladder. He was previously COO & CFO of Vessix Vascular, a medical device company treating resistant hypertension that was acquired by Boston Scientific Corporation in November 2012. Dan has played a key role in building several venture capital financed companies and has expertise in building teams, raising capital, structuring license agreements, and mergers and acquisitions. He started his career as a CPA in the healthcare group at Ernst & Young in Dallas, Texas. Dan earned his MBA from Boston College and his BBA from Southern Methodist University.